STOCK TITAN

Bausch & Lomb (BLCO) legal chief buys shares and receives 14,600 matching RSUs

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Bausch & Lomb Corp executive Robert D. Bailey, EVP & Chief Legal Officer, reported new activity in company stock. On March 6, 2026, he made an open-market purchase of 14,600 common shares at an average price of $17.146 per share, held in his self-directed IRAs.

In connection with this purchase, he also acquired 14,600 matching restricted share units (MRSUs) under the company’s matching share program. These MRSUs vest in three equal annual installments over three years, contingent on his continued service, bringing his direct holdings to 246,490 common shares after the reported transactions.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bailey A Robert D

(Last) (First) (Middle)
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT

(Street)
VAUGHAN A6 L4K 4B4

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares, No Par Value 03/06/2026 P 14,600(1) A $17.146(2) 231,890 D
Common Shares, No Par Value 03/06/2026 A 14,600(3) A $0 246,490 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares are held by the reporting person's self-directed IRAs.
2. Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.101 to $17.20 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
3. Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).
/s/ Debra E. Levin, attorney-in-fact 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Bausch & Lomb (BLCO) report for Robert D. Bailey?

Robert D. Bailey reported an open-market purchase of 14,600 common shares of Bausch & Lomb at an average price of $17.146 per share. He also received 14,600 matching restricted share units under the company’s matching share program tied to this purchase.

How many Bausch & Lomb (BLCO) shares does Robert D. Bailey own after this Form 4?

Following the reported transactions, Robert D. Bailey directly holds 246,490 common shares of Bausch & Lomb. This figure reflects both the open-market purchase and the grant of matching restricted share units disclosed in the Form 4 filing.

At what price did Robert D. Bailey buy Bausch & Lomb (BLCO) shares?

Robert D. Bailey purchased 14,600 Bausch & Lomb common shares at a weighted average price of about $17.146 per share. The filing notes multiple individual trades within a price range from $17.101 to $17.20 inclusive.

What are the matching restricted share units (MRSUs) granted to Bailey at BLCO?

Bailey received 14,600 matching restricted share units in connection with his open-market purchase under Bausch & Lomb’s matching share program. One-third of these MRSUs will vest on each of the first three anniversaries of the grant date, subject to continued service.

How are Robert D. Bailey’s new BLCO shares held according to the Form 4 footnotes?

The filing explains that the purchased 14,600 common shares are held in Robert D. Bailey’s self-directed IRAs. The ownership is reported as direct, and the Form 4 clarifies that the shares were bought in multiple transactions within the specified price range.

Did the Bausch & Lomb (BLCO) Form 4 include any derivative or option exercises?

No derivative or option exercises are reported in this Form 4. The transactions involve non-derivative common shares: an open-market purchase of 14,600 shares and a grant of 14,600 matching restricted share units, with no derivative positions listed in the derivative summary.
Bausch + Lomb Corporation

NYSE:BLCO

View BLCO Stock Overview

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

6.10B
38.39M
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN